Literature DB >> 23159624

Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting.

Jeffrey M Chamberlain1, Colleen O'Dell, Charles E Sparks, Janet D Sparks.   

Abstract

Insulin suppresses secretion of very low density lipoprotein (VLDL) apolipoprotein (apo) B in primary rodent hepatocytes (RH) by favoring the degradation of B100, the larger form of apo B, through post-endoplasmic reticulum proteolysis. Sortilin 1 (sort1), a multi-ligand sorting receptor, has been proposed as a mediator of lysosomal B100 degradation by directing B100 in pre-VLDL to lysosomes rather than allowing maturation to VLDL and secretion. The purpose of our studies was to investigate the role of sort1 in insulin-dependent degradation of apo B. Using liver derived McArdle RH7777 (McA) cells, we demonstrate that insulin suppresses VLDL B100 secretion via a phosphatidylinositide 3-kinase (PI3K) dependent process that is inhibitable by wortmannin in a fashion similar to RH. Using McA cells and in situ cross-linking, we demonstrate that insulin acutely (30min) stimulates the interaction of B100 with sort1. The insulin-induced interaction of sort1-B100 is markedly enhanced when lysosomal degradation is inhibited by Bafilomycin A1 (BafA1), an inhibitor of lysosomal acidification. As BafA1 also prevents insulin suppressive effects on apo B secretion, our results suggest that sort1-B100 interaction stimulated by insulin transiently accumulates with BafA1 and favors B100 secretion by default.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159624      PMCID: PMC3544973          DOI: 10.1016/j.bbrc.2012.11.022

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice.

Authors:  Doru V Chirieac; Nicholas O Davidson; Charles E Sparks; Janet D Sparks
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-06-22       Impact factor: 4.052

2.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.

Authors:  Kiran Musunuru; Alanna Strong; Maria Frank-Kamenetsky; Noemi E Lee; Tim Ahfeldt; Katherine V Sachs; Xiaoyu Li; Hui Li; Nicolas Kuperwasser; Vera M Ruda; James P Pirruccello; Brian Muchmore; Ludmila Prokunina-Olsson; Jennifer L Hall; Eric E Schadt; Carlos R Morales; Sissel Lund-Katz; Michael C Phillips; Jamie Wong; William Cantley; Timothy Racie; Kenechi G Ejebe; Marju Orho-Melander; Olle Melander; Victor Koteliansky; Kevin Fitzgerald; Ronald M Krauss; Chad A Cowan; Sekar Kathiresan; Daniel J Rader
Journal:  Nature       Date:  2010-08-05       Impact factor: 49.962

3.  Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export.

Authors:  Mads Kjolby; Olav M Andersen; Tilman Breiderhoff; Anja W Fjorback; Karen Marie Pedersen; Peder Madsen; Pernille Jansen; Joerg Heeren; Thomas E Willnow; Anders Nykjaer
Journal:  Cell Metab       Date:  2010-09-08       Impact factor: 27.287

4.  Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.

Authors:  Janet D Sparks; Joanne Cianci; Jenny Jokinen; Li Sheng Chen; Charles E Sparks
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-22       Impact factor: 4.052

5.  Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice.

Authors:  Ding Ai; Juan M Baez; Hongfeng Jiang; Donna M Conlon; Antonio Hernandez-Ono; Maria Frank-Kamenetsky; Stuart Milstein; Kevin Fitzgerald; Andrew J Murphy; Connie W Woo; Alanna Strong; Henry N Ginsberg; Ira Tabas; Daniel J Rader; Alan R Tall
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

6.  Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies.

Authors:  Wei Qiu; Rita Kohen Avramoglu; Nadia Dubé; Taryne M Chong; Mark Naples; Crystal Au; Konstantinos G Sidiropoulos; Gary F Lewis; Jeffrey S Cohn; Michel L Tremblay; Khosrow Adeli
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 7.  APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation.

Authors:  N O Davidson; G S Shelness
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

Review 8.  The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.

Authors:  Henry N Ginsberg; Edward A Fisher
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

9.  Increased VLDL-triglyceride secretion precedes impaired control of endogenous glucose production in obese, normoglycemic men.

Authors:  Lars P Sørensen; Esben Søndergaard; Birgitte Nellemann; Jens S Christiansen; Lars C Gormsen; Søren Nielsen
Journal:  Diabetes       Date:  2011-08-01       Impact factor: 9.461

10.  Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?

Authors:  Daniel J Klionsky; Zvulun Elazar; Per O Seglen; David C Rubinsztein
Journal:  Autophagy       Date:  2008-10-22       Impact factor: 16.016

View more
  20 in total

Review 1.  Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease.

Authors:  David E Cohen; Edward A Fisher
Journal:  Semin Liver Dis       Date:  2013-11-12       Impact factor: 6.115

2.  "Trans-nonachlor increases extracellular free fatty acid accumulation and de novo lipogenesis to produce hepatic steatosis in McArdle-RH7777 cells".

Authors:  George Eli Howell; Erin McDevitt; Lucie Henein; Charlee Mulligan; Darian Young
Journal:  Toxicol In Vitro       Date:  2018-04-11       Impact factor: 3.500

3.  Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100.

Authors:  Jaume Amengual; Liang Guo; Alanna Strong; Julio Madrigal-Matute; Haizhen Wang; Susmita Kaushik; Jeffrey L Brodsky; Daniel J Rader; Ana Maria Cuervo; Edward A Fisher
Journal:  Circ Res       Date:  2018-01-04       Impact factor: 17.367

4.  Sortilin facilitates VLDL-B100 secretion by insulin sensitive McArdle RH7777 cells.

Authors:  Robert P Sparks; Wayne C Guida; Mark P Sowden; Jermaine L Jenkins; Matthew L Starr; Rutilio A Fratti; Charles E Sparks; Janet D Sparks
Journal:  Biochem Biophys Res Commun       Date:  2016-08-02       Impact factor: 3.575

5.  Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-07-08       Impact factor: 4.698

6.  The enigmatic role of sortilin in lipoprotein metabolism.

Authors:  Charles E Sparks; Robert P Sparks; Janet D Sparks
Journal:  Curr Opin Lipidol       Date:  2015-12       Impact factor: 4.776

7.  Phosphatidylinositol (3,4,5)-trisphosphate binds to sortilin and competes with neurotensin: Implications for very low density lipoprotein binding.

Authors:  Robert P Sparks; Jermaine L Jenkins; Gregory E Miner; Yan Wang; Wayne C Guida; Charles E Sparks; Rutilio A Fratti; Janet D Sparks
Journal:  Biochem Biophys Res Commun       Date:  2016-09-22       Impact factor: 3.575

8.  Insulin dependent apolipoprotein B degradation and phosphatidylinositide 3-kinase activation with microsomal translocation are restored in McArdle RH7777 cells following serum deprivation.

Authors:  Janet D Sparks; Amy L Magra; Jeffrey M Chamberlain; Colleen O'Dell; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2015-11-23       Impact factor: 3.575

9.  Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases.

Authors:  Janet D Sparks; Colleen O'Dell; Jeffrey M Chamberlain; Charles E Sparks
Journal:  Biochem Biophys Res Commun       Date:  2013-05-15       Impact factor: 3.575

10.  An Allosteric Binding Site on Sortilin Regulates the Trafficking of VLDL, PCSK9, and LDLR in Hepatocytes.

Authors:  Robert P Sparks; Andres S Arango; Jermaine L Jenkins; Wayne C Guida; Emad Tajkhorshid; Charles E Sparks; Janet D Sparks; Rutilio A Fratti
Journal:  Biochemistry       Date:  2020-11-05       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.